Smart syringes are medical devices engineered with safety mechanisms to prevent reuse of syringes and regulate unsafe injection practices. They are designed with features such as in-built inactivation mechanism to protect a person from needle stick injuries and blood-borne diseases such as hepatitis B and C and human immunodeficiency virus (HIV). They cater to a wide range of applications that include vaccination, drug delivery, and blood collection. Different types of smart syringes including auto disable (AD) syringes, passive safety syringes, and active safety syringes are used depending on the nature of application. Active safety syringes are the most commonly use type of syringes across all healthcare sectors, whereas auto disable (AD) syringes are the most popular syringes used for vaccination.
The global smart syringes market was evaluated at $6,870.19 million in 2019 and is estimated to garner $14,185.45 million by 2027, registering a CAGR of 8.7% during the forecast period. Increase in count of needle stick injuries; high prevalence of blood-borne transmission such as hepatitis B, C, and HIV through improper injection practices; growth in adoption of safety syringes; and advancements in technology drive the market growth. In addition, mandatory recommendations by the WHO to switch to smart syringes, ensuring safe injection practices is the major factor that boosts the market growth. However, high cost associated with smart syringes, especially passive safety syringes, low awareness in developing economies, and alternative drug delivery methods are expected to impede the market growth. The global smart syringes market volume is projected to reach 28,078.73 units by 2027, and is projected to grow at a CAGR of 8.9% during the forecast period.
Similarly, the volume of smart syringes to be used in coming years is expected to witness a sharp increase, owing to the COVID-19 immunization programs that are pre-planned across the world. COVID-19 infection has already proven its ability to create medical equipment shortages such as supply of gowns, face masks, and personal protective equipment (PPE) within early days of the pandemic. Thus, to overcome such supply chain issues, governments and organizations have already started syringe manufacturing and production, as they are one of the vital components of vaccine delivery. This demand for global vaccination against novel coronavirus is wholly prepared to propel smart syringe manufacturing throughout the pandemic phase.
The global smart syringes market is segmented on the basis of product, application, age group, end user, and region. The product segment is categorized into auto disable (AD) syringes, active safety syringes, and passive safety syringes. The active safety syringe segment accounted for the highest revenue in 2019, owing to established market position. Furthermore, auto disable (AD) syringes are especially used for vaccination purposes and are designed specifically for single use, embedded with an internal mechanism that blocks the barrel once used, which prevents its further usage. The global smart syringes market, by application is divided into drug delivery, vaccination, and blood specimen collection. The drug delivery segment generated highest revenue in 2019. Several advantages, such as better bioavailability of intravenous drugs, shorter onset time, and accurate titration of dosage associated with syringes boost the market growth.
Depending on age group, the smart syringes market is bifurcated into pediatrics and adults. By end user, it is classified into hospitals & HMOs (Health Maintenance Organization), diabetic patients, family practices, psychiatrics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2019, and is expected to remain dominant throughout the forecast period, owing to increase in adoption of smart syringes, high awareness among consumers about smart syringes, and high healthcare expenditure across the region.
Competitive intelligence of prominent manufacturers regarding smart syringes provide key insights in terms of strategies implemented to gain significant share in the smart syringes market. Becton, Dickinson & Company is the leading player that provides a wide range of smart syringes across the healthcare sector worldwide. Smart syringes provided by Becton, Dickinson & Company include BD Integra retracting syringe, BD Safety-Lok syringe, and BD SafetyGlide syringe.
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
By Product
By Application
By Age Group
By End user
By Region
KEY MARKET PLAYERS
The other companies operating in the smart syringe market are Axel Bio Corporation, Inc., DMC Medical Limited, Pharmstandard pharmaceutical company, Sharps Technology, Inc., Sol-Millennum and Zarys.
The global smart syringes market was evaluated at $6,870.19 million in 2019 and is estimated to garner $14,185.45 million by 2027, registering a CAGR of 8.7% during the forecast period. Increase in count of needle stick injuries; high prevalence of blood-borne transmission such as hepatitis B, C, and HIV through improper injection practices; growth in adoption of safety syringes; and advancements in technology drive the market growth. In addition, mandatory recommendations by the WHO to switch to smart syringes, ensuring safe injection practices is the major factor that boosts the market growth. However, high cost associated with smart syringes, especially passive safety syringes, low awareness in developing economies, and alternative drug delivery methods are expected to impede the market growth. The global smart syringes market volume is projected to reach 28,078.73 units by 2027, and is projected to grow at a CAGR of 8.9% during the forecast period.
Similarly, the volume of smart syringes to be used in coming years is expected to witness a sharp increase, owing to the COVID-19 immunization programs that are pre-planned across the world. COVID-19 infection has already proven its ability to create medical equipment shortages such as supply of gowns, face masks, and personal protective equipment (PPE) within early days of the pandemic. Thus, to overcome such supply chain issues, governments and organizations have already started syringe manufacturing and production, as they are one of the vital components of vaccine delivery. This demand for global vaccination against novel coronavirus is wholly prepared to propel smart syringe manufacturing throughout the pandemic phase.
The global smart syringes market is segmented on the basis of product, application, age group, end user, and region. The product segment is categorized into auto disable (AD) syringes, active safety syringes, and passive safety syringes. The active safety syringe segment accounted for the highest revenue in 2019, owing to established market position. Furthermore, auto disable (AD) syringes are especially used for vaccination purposes and are designed specifically for single use, embedded with an internal mechanism that blocks the barrel once used, which prevents its further usage. The global smart syringes market, by application is divided into drug delivery, vaccination, and blood specimen collection. The drug delivery segment generated highest revenue in 2019. Several advantages, such as better bioavailability of intravenous drugs, shorter onset time, and accurate titration of dosage associated with syringes boost the market growth.
Depending on age group, the smart syringes market is bifurcated into pediatrics and adults. By end user, it is classified into hospitals & HMOs (Health Maintenance Organization), diabetic patients, family practices, psychiatrics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2019, and is expected to remain dominant throughout the forecast period, owing to increase in adoption of smart syringes, high awareness among consumers about smart syringes, and high healthcare expenditure across the region.
Competitive intelligence of prominent manufacturers regarding smart syringes provide key insights in terms of strategies implemented to gain significant share in the smart syringes market. Becton, Dickinson & Company is the leading player that provides a wide range of smart syringes across the healthcare sector worldwide. Smart syringes provided by Becton, Dickinson & Company include BD Integra retracting syringe, BD Safety-Lok syringe, and BD SafetyGlide syringe.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2027, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global smart syringe market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Product
- Auto Disable Syringes
- Active Safety Syringes
- Passive Safety Syringes
By Application
- Drug Delivery
- Vaccination
- Blood Specimen Collection
By Age Group
- Pediatrics
- Adults
By End user
- Hospitals & HMOs
- Diabetic patients
- Family practices (Physicians)
- Psychiatrics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Gerresheimer AG
- Merit Medical
- Nipro Corporation
- Retractable Technologies, Inc.
- Revolutions Medical Corporation
- Smiths Group Plc
- Terumo Corporation
The other companies operating in the smart syringe market are Axel Bio Corporation, Inc., DMC Medical Limited, Pharmstandard pharmaceutical company, Sharps Technology, Inc., Sol-Millennum and Zarys.
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Smart Syringes Market, by Product
Chapter 5: Smart Syringes Market, by Application
Chapter 6: Smart Syringes Market, by Age Group
Chapter 7: Smart Syringes Market, by End-user
Chapter 8: Smart Syringes Market, by Region
Chapter 9: Company Profiles
List of Tables
List of Figures
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 291 |
| Published | September 2020 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 6870.19 million |
| Forecasted Market Value ( USD | $ 14185.45 million |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
